Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

Shares of Moderna rose after the company said that the government of Canada authorized its updated Covid-19 vaccine, joining the U.S. in the approval. The stock was up 4.5% at $72.28 in Tuesday ...

TORONTO - Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA vaccine, called Spikevax, has been ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada "within days," a spokesperson for the Public Health Agency of Canada says, although availability will depend on ...

TORONTO — Health Canada authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday. We apologize, but this video has failed to load.

ACCESSWIRE • 9 days ago EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.